OTC Pharmaceuticals: Global Industry Guide : Market Research Report

OTC Pharmaceuticals: Global Industry Guide

Published by: Datamonitor

Published: Feb. 28, 2008 - 355 Pages

CHAPTER 1 INTRODUCTION: 1.1 What is this report about?; 1.2 Who is the target reader?; 1.3 How to use this report; 1.4 Definitions
CHAPTER 2 Global OTC Pharmaceuticals: 2.1 Market Overview; 2.2 Market Value; 2.3 Market Segmentation I; 2.4 Market Segmentation II; 2.5 Market Share; 2.6 Five Forces Analysis; 2.7 Leading Companies; 2.8 Distribution; 2.9 Market Forecasts
CHAPTER 3 OTC Pharmaceuticals in Asia-Pacific: 3.1 Market Overview; 3.2 Market Value; 3.3 Market Segmentation I; 3.4 Market Segmentation II; 3.5 Market Share; 3.6 FIVE FORCES ANALYSIS; 3.7 Leading Companies; 3.8 Distribution; 3.9 Market Forecasts
CHAPTER 4 OTC Pharmaceuticals in Europe: 4.1 Market Overview; 4.2 Market Value; 4.3 Market Segmentation I; 4.4 Market Segmentation II; 4.5 Market Share; 4.6 Five Forces Analysis; 4.7 Leading Companies; 4.8 Distribution; 4.9 Market Forecasts; 4.10 Macroeconomic Indicators
CHAPTER 5 OTC Pharmaceuticals in Belgium: 5.1 Market Overview; 5.2 Market Value; 5.3 Market Segmentation I; 5.4 Market Segmentation II; 5.5 Market Share; 5.6 FIVE FORCES ANALYSIS; 5.7 Leading Companies; 5.8 Distribution; 5.9 Market Forecasts; 5.10 Macroeconomic Indicators
CHAPTER 6 OTC Pharmaceuticals in Canada: 6.1 Market Overview; 6.2 Market Value; 6.3 Market Segmentation I; 6.4 Market Segmentation II; 6.5 Market Share; 6.6 FIVE FORCES ANALYSIS; 6.7 Leading Companies; 6.8 Distribution; 6.9 Market Forecasts; 6.10 Macroeconomic Indicators
CHAPTER 7 OTC Pharmaceuticals in China: 7.1 Market Overview; 7.2 Market Value; 7.3 Market Segmentation I; 7.4 Market Segmentation II; 7.5 Market Share; 7.6 FIVE FORCES ANALYSIS; 7.7 Leading Companies; 7.8 Distribution; 7.9 Market Forecasts; 7.10 Macroeconomic Indicators
CHAPTER 8 OTC Pharmaceuticals in France: 8.1 Market Overview; 8.2 Market Value; 8.3 Market Segmentation I; 8.4 Market Segmentation II; 8.5 Market Share; 8.6 Five Forces Analysis; 8.7 Leading Companies; 8.8 Distribution; 8.9 Market Forecasts; 8.10 Macroeconomic Indicators
CHAPTER 9 OTC Pharmaceuticals in Germany: 9.1 Market Overview; 9.2 Market Value; 9.3 Market Segmentation I; 9.4 Market Segmentation II; 9.5 Market Share; 9.6 Five Forces Analysis; 9.7 Leading Companies; 9.8 Distribution; 9.9 Market Forecasts; 9.10 Macroeconomic Indicators
CHAPTER 10 OTC Pharmaceuticals in Italy: 10.1 Market Overview; 10.2 Market Value; 10.3 Market Segmentation I; 10.4 Market Segmentation II; 10.5 Market Share; 10.6 FIVE FORCES ANALYSIS; 10.7 Leading Companies; 10.8 Distribution; 10.9 Market Forecasts; 10.10 Macroeconomic Indicators
CHAPTER 11 OTC Pharmaceuticals in Japan: 11.1 Market Overview; 11.2 Market Value; 11.3 Market Segmentation I; 11.4 Market Segmentation II; 11.5 Market Share; 11.6 Five Forces Analysis; 11.7 Leading Companies; 11.8 Distribution; 11.9 Market Forecasts; 11.10 Macroeconomic Indicators
CHAPTER 12 OTC Pharmaceuticals in the Netherlands: 12.1 Market Overview; 12.2 Market Value; 12.3 Market Segmentation I; 12.4 Market Segmentation II; 12.5 Market Share; 12.6 FIVE FORCES ANALYSIS; 12.7 Leading Companies; 12.8 Distribution; 12.9 Market Forecasts; 12.10 Macroeconomic Indicators
CHAPTER 13 OTC Pharmaceuticals in Spain: 13.1 Market Overview; 13.2 Market Value; 13.3 Market Segmentation I; 13.4 Market Segmentation II; 13.5 Market Share; 13.6 FIVE FORCES ANALYSIS; 13.7 Leading Companies; 13.8 Distribution; 13.9 Market Forecasts; 13.10 Macroeconomic Indicators
CHAPTER 14 OTC Pharmaceuticals in the United Kingdom: 14.1 Market Overview; 14.2 Market Value; 14.3 Market Segmentation I; 14.4 Market Segmentation II; 14.5 Market Share; 14.6 Five Forces Analysis; 14.7 Leading Companies; 14.8 Distribution; 14.9 Market Forecasts; 14.10 Macroeconomic Indicators
CHAPTER 15 OTC Pharmaceuticals in the United States: 15.1 Market Overview; 15.2 Market Value; 15.3 Market Segmentation I; 15.4 Market Segmentation II; 15.5 Market Share; 15.6 Five Forces Analysis; 15.7 Leading Companies; 15.8 Distribution; 15.9 Market Forecasts; 15.10 Macroeconomic Indicators
CHAPTER 16 Appendix: 16.1 Methodology; 16.2 Industry Associations; 16.3 Related Datamonitor Research
LIST OF TABLES: Table 1: Global OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 2: Global OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 3: Global OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 4: Global OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 5: Key Facts: Pfizer Inc; Table 6: Key Financials: Pfizer Inc; Table 7: Key Facts: GlaxoSmithKline Plc; Table 8: Key Financials: GlaxoSmithKline Plc; Table 9: Key Facts: Novartis AG; Table 10: Key Financials: Novartis AG; Table 11: Global OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 12: Global OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 13: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 14: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 15: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 16: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 17: Key Facts: Nin Jiom; Table 18: Key Facts: Pfizer Inc; Table 19: Key Financials: Pfizer Inc; Table 20: Key Facts: Novartis AG; Table 21: Key Financials: Novartis AG; Table 22: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 23: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 24: Europe OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 25: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 26: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 27: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 28: Key Facts: Bayer AG; Table 29: Key Financials: Bayer AG; Table 30: Key Facts: Pfizer Inc; Table 31: Key Financials: Pfizer Inc; Table 32: Key Facts: GlaxoSmithKline Plc; Table 33: Key Financials: GlaxoSmithKline Plc; Table 34: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 35: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 36: Europe Exchange Rate, 2003; Table 37: Belgium OTC Pharmaceuticals Market Value: $ million, 2003-2007; Table 38: Belgium OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 39: Belgium OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 40: Belgium OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 41: Key Facts: Pfizer Inc; Table 42: Key Financials: Pfizer Inc; Table 43: Key Facts: Novartis AG; Table 44: Key Financials: Novartis AG; Table 45: Key Facts: Omega Pharma NV; Table 46: Key Financials: Omega Pharma NV; Table 47: Belgium OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 48: Belgium OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012; Table 49: Belgium Size of Population (million) , 2003-2007; Table 50: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 51: Belgium Inflation, 2003-2007; Table 52: Belgium Exchange Rate, 2003; Table 53: Canada OTC Pharmaceuticals Market Value: $ million, 2003-2007; Table 54: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 55: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 56: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 57: Key Facts: Pfizer Inc; Table 58: Key Financials: Pfizer Inc; Table 59: Key Facts: GlaxoSmithKline Plc; Table 60: Key Financials: GlaxoSmithKline Plc; Table 61: Key Facts: Jamieson Laboratories; Table 62: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 63: Canada OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012; Table 64: Canada Size of Population (million) , 2003-2007; Table 65: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 66: Canada Inflation, 2003-2007; Table 67: Canada Exchange Rate, 2003; Table 68: China OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 69: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 70: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 71: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 72: Key Facts: Johnson & Johnson; Table 73: Key Financials: Johnson & Johnson; Table 74: China OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 75: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 76: China Size of Population (million) , 2003-2007; Table 77: China GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 78: China Inflation, 2003-2007; Table 79: China Exchange Rate, 2003; Table 80: France OTC Pharmaceuticals Market Value: $ million, 2003-2007; Table 81: France OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 82: France OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 83: France OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 84: Key Facts: Procter & Gamble Company, The; Table 85: Key Financials: Procter & Gamble Company, The; Table 86: Key Facts: Sanofi-Aventis; Table 87: Key Financials: Sanofi-Aventis; Table 88: Key Facts: Pfizer Inc; Table 89: Key Financials: Pfizer Inc; Table 90: France OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 91: France OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012; Table 92: France Size of Population (million) , 2003-2007; Table 93: France GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 94: France Inflation, 2003-2007; Table 95: France Exchange Rate, 2003; Table 96: Germany OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 97: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 98: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 99: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 100: Key Facts: Bayer AG; Table 101: Key Financials: Bayer AG; Table 102: Key Facts: Pfizer Inc; Table 103: Key Financials: Pfizer Inc; Table 104: Key Facts: GlaxoSmithKline Plc; Table 105: Key Financials: GlaxoSmithKline Plc; Table 106: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 107: Germany OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 108: Germany Size of Population (million) , 2003-2007; Table 109: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 110: Germany Inflation, 2003-2007; Table 111: Germany Exchange Rate, 2003; Table 112: Italy OTC Pharmaceuticals Market Value: $ million, 2003-2007; Table 113: Italy OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 114: Italy OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 115: Italy OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 116: Key Facts: Boehringer Ingelheim GmbH; Table 117: Key Financials: Boehringer Ingelheim GmbH; Table 118: Key Facts: Bayer AG; Table 119: Key Financials: Bayer AG; Table 120: Key Facts: GlaxoSmithKline Plc; Table 121: Key Financials: GlaxoSmithKline Plc; Table 122: Italy OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 123: Italy OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012; Table 124: Italy Size of Population (million) , 2003-2007; Table 125: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 126: Italy Inflation, 2003-2007; Table 127: Italy Exchange Rate, 2003; Table 128: Japan OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 129: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 130: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 131: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 132: Key Facts: Pfizer Inc; Table 133: Key Financials: Pfizer Inc; Table 134: Key Facts: Novartis AG; Table 135: Key Financials: Novartis AG; Table 136: Key Facts: Wyeth; Table 137: Key Financials: Wyeth; Table 138: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 139: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 140: Japan Size of Population (million) , 2003-2007; Table 141: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 142: Japan Exchange Rate, 2003; Table 143: Netherlands OTC Pharmaceuticals Market Value: $ million, 2003-2007; Table 144: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 145: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 146: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 147: Key Facts: Bayer AG; Table 148: Key Financials: Bayer AG; Table 149: Key Facts: Pfizer Inc; Table 150: Key Financials: Pfizer Inc; Table 151: Key Facts: Procter & Gamble Company, The; Table 152: Key Financials: Procter & Gamble Company, The; Table 153: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 154: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012; Table 155: Netherlands Size of Population (million) , 2003-2007; Table 156: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 157: Netherlands Inflation, 2003-2007; Table 158: Netherlands Exchange Rate, 2003; Table 159: Spain OTC Pharmaceuticals Market Value: $ million, 2003-2007; Table 160: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 161: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 162: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 163: Key Facts: Pfizer Inc; Table 164: Key Financials: Pfizer Inc; Table 165: Key Facts: GlaxoSmithKline Plc; Table 166: Key Financials: GlaxoSmithKline Plc; Table 167: Key Facts: Sanofi-Aventis; Table 168: Key Financials: Sanofi-Aventis; Table 169: Spain OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 170: Spain OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012; Table 171: Spain Size of Population (million) , 2003-2007; Table 172: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 173: Spain Inflation, 2003-2007; Table 174: Spain Exchange Rate, 2003; Table 175: United Kingdom OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 176: United Kingdom OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 177: United Kingdom OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 178: United Kingdom OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 179: Key Facts: Pfizer Inc; Table 180: Key Financials: Pfizer Inc; Table 181: Key Facts: GlaxoSmithKline Plc; Table 182: Key Financials: GlaxoSmithKline Plc; Table 183: Key Facts: Reckitt Benckiser PLC; Table 184: Key Financials: Reckitt Benckiser PLC; Table 185: United Kingdom OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 186: United Kingdom OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 187: United Kingdom Size of Population (million) , 2003-2007; Table 188: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 189: United Kingdom Inflation, 2003-2007; Table 190: United Kingdom Exchange Rate, 2003; Table 191: United States OTC Pharmaceuticals Market Value: $ billion, 2003-2007; Table 192: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007; Table 193: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007; Table 194: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007; Table 195: Key Facts: Wyeth; Table 196: Key Financials: Wyeth; Table 197: Key Facts: Pfizer Inc; Table 198: Key Financials: Pfizer Inc; Table 199: Key Facts: GlaxoSmithKline Plc; Table 200: Key Financials: GlaxoSmithKline Plc; Table 201: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2007; Table 202: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012; Table 203: United States Size of Population (million) , 2003-2007; Table 204: United States GDP (Constant 2000 Prices, $ billion), 2003-2007; Table 205: United States Inflation, 2003-2007

Abstract

Datamonitor's OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

Contains an executive summary and data on value, volume and segmentation
Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
Incorporates in-depth five forces competitive environment analysis and scorecards
Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
Includes a five-year forecast of the industry

Highlights

The global OTC pharmaceuticals market grew by 4% in 2007 to reach a value of $84.8 billion.
In 2012, the global OTC pharmaceuticals market is forecast to have a value of $101.8 billion, an increase of 20.1% since 2007.
Cough and cold preparations form the most lucrative sector of the global market, with an 18.4% share of the market by value.
The Asia-Pacific is the leading region in the global market, with a 38.8% share of the total market value.
Pfizer Inc. is the leading company in the global market, with a 6.3% share of the market by value.
Pharmacies and drugstores form the most lucrative distribution channel, with a 67.2% share of the global market by value.

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

OTC Pharmaceuticals: Global Industry Guide

Table of Contents

Abstract